Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Immunotherapy ====== {{rss>https://pubmed.ncbi.nlm.nih.gov/rss/search/1BWfEy0KKtyekmOtRwjEFeEF7_nolVqVyhNbdF38CVHORMK5Q3/?limit=15&utm_campaign=pubmed-2&fc=20231211030856}} ---- ---- Immunotherapy is a type of [[medical treatment]] that harnesses the body's own [[immune system]] to combat diseases, particularly [[cancer]] and certain [[autoimmune]] disorders. The [[immune system]] is a complex network of [[cell]]s, [[tissue]]s, and molecules that work together to defend the body against harmful invaders like [[bacteria]], [[virus]]es, and abnormal cells. ===== Types ===== [[Combination immunotherapy]]. [[CAR-T cell therapy]] [[Monoclonal Antibody]] [[Immune Checkpoint Inhibitor]] and combinations ===== Cancer Immunotherapy ===== see [[Cancer Immunotherapy]]. [[Glioblastoma Immunotherapy]]. ===== Stroke ===== The immune reaction during ischemia opens new doors for advanced targeted therapeutics. Nowadays stem cell therapy has shown better results in stroke-prone individuals. Few monoclonal antibodies like [[natalizumab]] have shown a great impact on pre-clinical and clinical stroke trial studies ((Chavda V, Madhwani K, Chaurasia B. [[Stroke]] and [[Immunotherapy]]: Potential Mechanisms and its implications as immune-therapeutics. Eur J Neurosci. 2021 Apr 7. doi: 10.1111/ejn.15224. Epub ahead of print. PMID: 33829590.)). immunotherapy.txt Last modified: 2024/06/07 02:57by 127.0.0.1